Abstract
Fibromyalgia (FM) represents a condition that is still controversial in its entity, pathophysiology, diagnosis and management. The aim of this review is to focus on imaging aspects of FM, especially on novel approaches in molecular imaging, with a special focus on neuroimaging. Novel functional and molecular imaging findings may represent, eventually, future biomarkers both in research settings and in terms of clinical practice. Several imaging techniques have already been tested in clinical trials in the FM field, including functional MRI, positron emission tomography (PET) imaging with 18F-FDG in FM, PET imaging of the dopaminergic system, PET imaging of the GABAergic system, PET imaging with neuroinflammation and neuroimmune parameters, PET imaging of the opioid system and H215O-PET activation studies. Therefore, the potential role in the FM field of fMRI and different PET tracers has been discussed in different settings, serving as a comprehensive guide of novel imaging options both in research and in the clinical field.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference74 articles.
1. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers;Gerra;Mol. Pain,2019
2. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria;Wolfe;Semin. Arthritis Rheum.,2016
3. Fibrofog and fibromyalgia: A narrative review and implications for clinical practice;Kravitz;Rheumatol. Int.,2015
4. Fibromyalgia: A misconnection in a multiconnected world?;Perrot;Eur. J. Pain,2019
5. ¿Es la fibromialgia una enfermedad neurológica? [Is fibromyalgia a neurological disease?];Arias;Neurologia,2008
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献